Conditions: Sarcoma, Soft Tissue
Keywords: Sarcoma Synovial sarcoma Pazopanib(GW786034) Adipocytic tumors Leiomyosarcoma Phase II
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 148
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the activity and tolerability of pazopanib in subjects with advanced and/or metastatic soft tissue sarcoma who have relapsed following standard therapies or for whom no standard therapy exists and to characterize the pharmacokinetics of pazopanib in this subject population.

Detailed description:

Arms:

Interventions: intervention 1: pazopanib
Intervention descriptions: intervention 1: oral tablet

Protocol document: